Tiragolumab Treatment Combo Misses Mark in Advanced Liver Cancer
Adding Tecentriq (atezolizumab) to Tecentriq plus Avastin (bevacizumab) and tiragolumab treatment did not show an added benefit in patients with...
Liver Cancer Healthcare
Boosting Liver Cancer Treatment: Radiation Plus Immunotherapy
In the relentless pursuit of more effective treatments for advanced hepatocellular carcinoma (HCC), a groundbreaking meta-analysis recently published has cast...
This common liver supplement could boost cancer treatment success
Immunotherapy is a cancer treatment that harnesses the body's own immune defenses to attack tumors. It has shown remarkable success...
ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
Know the Risks, Know the Signs
DETROIT, Oct. 13, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute, cancer centers, and other organizations nationwide recognize October...
Critical analysis of the liver cancer policies and programs in China: implications for international liver cancer control | Global Health Research and Policy
Sia D, Villanueva A, Friedman SL, Llovet JM. Liver cancer cell of origin, molecular class, and effects on patient prognosis....
